These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35767128)

  • 21. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of non-hydroxamate scaffolds against HDAC6 inhibition: A pharmacophore modeling, molecular docking, and molecular dynamics simulation approach.
    Zeb A; Park C; Son M; Rampogu S; Alam SI; Park SJ; Lee KW
    J Bioinform Comput Biol; 2018 Jun; 16(3):1840015. PubMed ID: 29945500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors.
    Tian Y; Xu J; Li Z; Zhu Z; Zhang J; Wu S
    Int J Mol Sci; 2011; 12(8):5080-97. PubMed ID: 21954347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined 3D-QSAR, molecular docking, and molecular dynamics study of tacrine derivatives as potential acetylcholinesterase (AChE) inhibitors of Alzheimer's disease.
    Zhou A; Hu J; Wang L; Zhong G; Pan J; Wu Z; Hui A
    J Mol Model; 2015 Oct; 21(10):277. PubMed ID: 26438408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods.
    Pourbasheer E; Aalizadeh R
    SAR QSAR Environ Res; 2016 May; 27(5):385-407. PubMed ID: 27228480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
    Dowlati Beirami A; Hajimahdi Z; Zarghi A
    J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved 3D-QSAR Prediction by Multiple Conformational Alignments and Molecular Docking Studies to Design and Discover HIV-I Protease Inhibitors.
    Patel PK; Bhatt HG
    Curr HIV Res; 2021; 19(2):154-171. PubMed ID: 33213349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigations of retinoic acid receptor-related orphan receptor-gamma t (RORγt) agonists: a combination of 3D-QSAR, molecular docking and molecular dynamics.
    Chen Q; Wang F; Zhou B
    J Biomol Struct Dyn; 2021 Jul; 39(10):3501-3514. PubMed ID: 32375589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel acetylcholinesterase inhibitors through 3D-QSAR, molecular docking, and molecular dynamics simulation targeting Alzheimer's disease.
    El Khatabi K; El-Mernissi R; Aanouz I; Ajana MA; Lakhlifi T; Khan A; Wei DQ; Bouachrine M
    J Mol Model; 2021 Sep; 27(10):302. PubMed ID: 34581863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the structural features of JAK2 inhibitors: a combined 3D-QSAR, DFT and molecular dynamics study.
    Babu S; Nagarajan SK; Madhavan T
    Mol Divers; 2019 Nov; 23(4):845-874. PubMed ID: 30617940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the binding mechanism of novel 6-aminonicotinate-based antagonists with P2Y
    Zhou S; Fang D; Tan S; Lin W; Wu W; Zheng K
    J Biomol Struct Dyn; 2017 Oct; 35(13):2938-2965. PubMed ID: 27634290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fragment-Based Drug Design of Selective HDAC6 Inhibitors.
    Ruzic D; Djokovic N; Nikolic K
    Methods Mol Biol; 2021; 2266():155-170. PubMed ID: 33759126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design Two Novel Tetrahydroquinoline Derivatives against Anticancer Target LSD1 with 3D-QSAR Model and Molecular Simulation.
    Xu Y; Fan B; Gao Y; Chen Y; Han D; Lu J; Liu T; Gao Q; Zhang JZ; Wang M
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding site analysis of CCR2 through in silico methodologies: docking, CoMFA, and CoMSIA.
    Kothandan G; Gadhe CG; Madhavan T; Cho SJ
    Chem Biol Drug Des; 2011 Jul; 78(1):161-74. PubMed ID: 21294847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
    Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
    Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
    Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico exploration of aryl sulfonamide analogs as voltage-gated sodium channel 1.7 inhibitors by using 3D-QSAR, molecular docking study, and molecular dynamics simulations.
    Wang M; Wang Y; Kong D; Jiang H; Wang J; Cheng M
    Comput Biol Chem; 2018 Dec; 77():214-225. PubMed ID: 30359866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
    Choubey SK; Jeyaraman J
    J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
    Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S
    Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virtual screening of PEBP1 inhibitors by combining 2D/3D-QSAR analysis, hologram QSAR, homology modeling, molecular docking analysis, and molecular dynamic simulations.
    Stitou M; Toufik H; Akabli T; Lamchouri F
    J Mol Model; 2022 May; 28(6):145. PubMed ID: 35545728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.